Frequently Asked Questions
The market is segmented based on Segmentation, By Type of Drug (Monoclonal Antibodies, Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha and Beta, Interleukins and Other Drugs), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases and Other Therapy Areas), End User (Hospitals, Clinics and Other End Users) - Industry Trends and Forecast to 2031.
.
The Global Immunotherapy Drugs Market size was valued at USD 225.96 USD Billion in 2023.
The Global Immunotherapy Drugs Market is projected to grow at a CAGR of 11.5% during the forecast period of 2024 to 2031.
The major players operating in the market include Abbott, PerkinElmer , Illumina , QIAGEN, F. Hoffmann-La Roche Ltd, Novartis AG, AstraZeneca, Pfizer , Sanofi, Johnson & Johnson Services , AbbVie , Allergan, Merck & Co. , Amgen , Thermo Fisher Scientific, Teva Pharmaceutical Industries , Takeda Pharmaceutical Company Limited., GlaxoSmithKline plc, Lupin Pharmaceuticals , Lilly, Bristol-Myers Squibb Company, Medtronic, Bayer AG, Boehringer Ingelheim International GmbH-.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
